Description
Finalgel (piroxicam) Gel 50 g
Ingredients
Active ingredient: Piroxicam
Other ingredients: Carbomer, isopropyl alcohol, purified water
Mechanism of Action
Piroxicam, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of prostaglandins, thereby reducing pain and inflammation by alleviating symptoms such as swelling, pain, and stiffness.
Indications for Use
Finalgel (piroxicam) gel is indicated for the relief of pain and inflammation associated with musculoskeletal conditions including arthritis, sprains, and strains.
Contraindications
Do not use Finalgel (piroxicam) gel if:
- You are allergic to piroxicam or other NSAIDs
- You have broken or irritated skin
Side Effects
Common side effects may include skin irritation, redness, or rash at the application site. If any severe reactions occur, discontinue use and seek medical advice.
Usage Instructions
Dosage: Apply a thin layer of Finalgel (piroxicam) gel to the affected area 3-4 times a day. Do not exceed the recommended dosage.
Directions:
- Clean and dry the affected area before application
- Gently massage the gel into the skin until fully absorbed
- Wash hands after application
Benefits Compared to Analogues
Finalgel (piroxicam) gel has shown superior efficacy in reducing pain and inflammation compared to some other topical NSAIDs, providing effective relief for musculoskeletal conditions.
Suitable Patient Groups
This product is suitable for adults, including the elderly, for the management of musculoskeletal pain and inflammation. Consult a healthcare professional for use in children.
Storage and Shelf Life
Store Finalgel (piroxicam) gel at room temperature, away from direct sunlight and moisture. Check the expiration date on the packaging and do not use after the specified date.
Packaging Description
The product is available in a 50 g tube for topical application. The packaging should be kept sealed when not in use.
Clinical Evidence and Proven Effectiveness
Studies have demonstrated the efficacy of piroxicam in reducing pain and inflammation in musculoskeletal conditions. A study published in the Journal of Rheumatology indicated the superior effectiveness of piroxicam gel over placebo in patients with osteoarthritis.
In a randomized controlled trial published in the Journal of Clinical Pharmacology, Finalgel (piroxicam) gel was compared to diclofenac gel for acute musculoskeletal injuries. Both treatments showed equal efficacy in pain reduction and functional improvement with no significant difference in adverse effects.
